Full formMedical & Health
TKIstands forTyrosine Kinase Inhibitor
Full Form of TKI
What is TKI?
TKI or Tyrosine Kinase Inhibitors represent a class of targeted therapy drugs that block specific enzymes called tyrosine kinases, which play a crucial role in the uncontrolled growth and spread of cancer cells. These inhibitors work by interfering with the cell signalling pathways that malignant tumours use to proliferate and develop new blood vessels, making them a cornerstone of modern precision oncology. In India, TKIs are widely prescribed by oncologists for treating chronic myeloid leukaemia, non-small cell lung cancer, breast cancer, renal cell carcinoma, and certain gastrointestinal stromal tumours. Popular TKIs available in the Indian pharmaceutical market include imatinib, erlotinib, gefitinib, sorafenib, and sunitinib, many of which are now manufactured domestically by Indian generic pharmaceutical companies, significantly reducing treatment costs for patients. The introduction of affordable generic versions through government initiatives and inclusion in the National List of Essential Medicines has improved access for lakhs of Indian cancer patients. Indian oncologists routinely prescribe TKIs in both government hospitals and private cancer centres across the country. For medical students preparing for NEET PG, INI-CET, and other postgraduate entrance examinations, understanding the mechanism of action, adverse effects, and clinical applications of TKIs remains an important high-yield topic in pharmacology and medical oncology.
TKI का फुल फॉर्म
टायरोसिन किनेज अवरोधक
Example
The senior oncologist at AIIMS Delhi prescribed imatinib, a widely used TKI, to the middle-aged patient newly diagnosed with chronic myeloid leukaemia.
TKI — frequently asked questions
What is the full form of TKI?
TKI stands for Tyrosine Kinase Inhibitor, a class of targeted therapy drugs that block enzymes responsible for the growth and multiplication of cancer cells in the body.
Which cancers are treated using TKIs in India?
In India, TKIs are commonly prescribed for chronic myeloid leukaemia, non-small cell lung cancer, breast cancer, renal cell carcinoma, and gastrointestinal stromal tumours.
Are TKI drugs available as affordable generics in India?
Yes, leading Indian pharmaceutical companies manufacture affordable generic versions of several TKIs, and many are included in government health schemes, making them accessible to lakhs of patients across the country.